Aug 2026· ACS Central Science· Vol 12, pp. 1360 - 1371· 1 citation· 88 references
Medicine
TL;DR
It is shown that oligomerization drives a transition from dynamic monomers to increasingly ordered intermediates, relevant to models in which α-syn oligomerization alters normal membrane engagement during PD-associated aggregation.
Abstract
The pathological aggregation of α-synuclein (α-syn), an intrinsically disordered protein that regulates synaptic vesicle trafficking in the brain, is a defining molecular feature in Parkinson’s disease (PD). Early oligomeric assemblies are widely considered the most neurotoxic species, yet their structural features remain unexplored due to their low abundance, transient, and fragile nature. Here, we establish a trapped ion mobility-mass spectrometry (TIMS-MS) strategy that enables direct detection and structural interrogation of these oligomers. Low-flow size exclusion chromatography provides MS-compatible desalting and reveals broad ensemble-level differences between fresh and aggregated α-syn. Native TIMS-MS measurements uniquely probe numerous higher-order oligomers, thereby revealing a reduced conformational heterogeneity with increasing oligomer size, supporting a linear β-strand-type assembly pathway. These findings show that oligomerization drives a transition from dynamic monomers to increasingly ordered intermediates. This progressive rigidification is relevant to models in which α-syn oligomerization alters normal membrane engagement during PD-associated aggregation.
A proteoform-by-environment model for IDP structure is established, in which phosphorylation effects are not fixed but are rewritten by the surrounding chemical environment, which distinguishes broad contact accessibility from the residue-level contacts that dominate each condition.
Ashlyn N. Dollar, Daniel W. Kelley, Ian K. Webb· Journal of the American Chem...· 0 citations
One of the challenges of modern structural biology is to account for protein structural dynamics. Intrinsically disordered proteins (IDPs), which do not fold spontaneously into a defined conformation, existing, instead, as highly heterogeneous conformational ensembles, provide an extreme and challenging example of prot...
S. Brocca, E. Ponzini, C. Santambrogio et al.· Frontiers in Biophysics· 0 citations
Heterotypic interactions with Aβ42 reshape α-syn aggregation pathways and fibril conformations, generating structurally distinct α-syn fibril populations with different neuronal seeding activities, which provide a molecular framework for understanding how cross-talk between amyloidogenic proteins may contribute to stru...
Purnopama Saha, Teshani Liyanaarachchige, Anika Alim et al.· bioRxiv· 0 citations
α-synuclein (αS), amyloid-β (Aβ), and Tau aggregates are hallmarks of many neurodegenerative diseases, yet the prevalence and nature of their nanoscopic co-assemblies remain poorly understood. Here, we adapt a single-molecule pull-down (SiMPull) assay to profile αS, Aβ, and Tau co-assemblies across post-mortem brain...
Yu P. Zhang, Amber Wallis, Clara Obensa Bertroli et al.· Nature Communications· 0 citations
Misfolded alpha-Synuclein (α-Syn) accumulation is the defining molecular pathology of Parkinson’s disease (PD), yet blood-based assays remain challenged by the high background of peripheral α-Syn originating mainly from red blood cells. Neuronal extracellular vesicles (EVs) circulating in blood offer a biologically enr...
Tian-Rui Chang, Cheng Jiang, Shi-Jun Yan et al.· Science Advances· 0 citations